NCT05726578

Brief Summary

The primary aim of this work is to evaluate the role of high frequency oscillatory ventilation (HFOV) in recruitment of lung in preterm newborns 32 to 37 weeks gestational age with moderate to severe respiratory distress. The secondary aim is to evaluate the role of chest ultrasound in monitoring of lung recruitment in comparison to routine chest x ray in those babies. Also cardiac hemodynamics will be assesed using functional echocardiography.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 14, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

February 3, 2023

Last Update Submit

May 24, 2025

Conditions

Keywords

Premature infants

Outcome Measures

Primary Outcomes (3)

  • chest US

    A mobile device (PHILIPS ® HD11 XE) with a 10-MHz linear probe will be used for chest ultrasound the 12 lung zones will be assessed regarding 1. presence Of A lines, B-lines or C-profile 2. presence or absence of pleural sliding

    first 3 days after birth

  • Superior Vena Cava flow in ml/kg/min

    Superior Vena Cava (SVC) Blood Flow using functional echocardiography

    first 3 days of life

  • estimated pulmonary artery pressure in mmHg

    Pulmonary artery pressure (PAP) will be assessed by measuring tricuspid valve regurgitation peak velocity: this will be measured in apical 4 chamber view, with continous wave Doppler using modified Bernoulli equation. Systolic pulmonary artery pressure is equivalent to right ventricular systolic pressure in absence of outflow obstruction. Systolic Pulmonary Artery Pressure (SPAP) = Right Ventricular Systolic Pressure = 4x TR2 + Right Atrial Pressure (RAP), with RAP= 3-5 mmHg.

    first 3 days of life

Study Arms (1)

Lung recruitment

EXPERIMENTAL

preterm infants with moderate to severe respiratory distress

Other: Lung recruitment

Interventions

establishment of lung recruitment using high frequency ventilation and assessment with chest ultrasound and echocardiography

Lung recruitment

Eligibility Criteria

Age1 Hour - 3 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants will be enrolled if they are 32 to 37 weeks of gestational age, have respiratory distress (RD) in the first 24 h of life, intubated and have invasive respiratory support using HFOV. Signs of RD are tachypnea (respiratory rate \> 60/min), grunting, nasal flaring, chest retraction, and need of oxygen supplementation or other respiratory support.

You may not qualify if:

  • Known major congenital anomalies including congenital heart diseases.
  • Fetal hydrops.
  • Babies with congenital heart diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Marwa Mohamed Farag

Alexandria, 0325, Egypt

RECRUITING

Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.

Alexandria, 21131, Egypt

NOT YET RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Mohamed Hazem Wagih Gouda, PhD

    Alexandria University

    STUDY CHAIR
  • Ali Mohamed Abd Almohsen, PhD

    Alexandria University

    STUDY DIRECTOR

Central Study Contacts

Marwa M Farag, PhD

CONTACT

Mohamed Hany Saad, MBBCh

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator and Lecturer in Pediatrics, Faculty of Medicine

Study Record Dates

First Submitted

February 3, 2023

First Posted

February 14, 2023

Study Start

July 1, 2024

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

May 28, 2025

Record last verified: 2025-05

Locations